Company profile: Benchling
1.1 - Company Overview
Company description
- Provider of a cloud-based platform for biology researchers and R&D organizations, including the Benchling R&D Cloud to centralize and standardize scientific data, enable collaboration, and provide insights; Benchling Bioresearch to design and manage experiments, biomolecules, workflows, and results; Benchling Notebook; plus CRISPR guide RNA design and sequence alignment tools.
Products and services
- Benchling Bioresearch: A digital workspace that architects and manages experiments, biomolecules, workflows, and results, delivering operational insights and collaboration features for biotech R&D teams
- Benchling Notebook: An integrated digital tool that captures and organizes experimental data, ensuring traceability and seamless integration with other Benchling tools used across research programs
- R&D Cloud: A cloud-based platform that centralizes and standardizes scientific data, enables team collaboration, and generates insights tailored for biotechnology R&D organizations
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Benchling
CLC Bio
HQ: Denmark
Website
- Description: Provider of bioinformatics solutions focused on analyzing data from all major high-throughput sequencing machines, including instruments from Illumina, Applied Biosystems (LIFE Technologies), Roche 454, Helicos, and Sanger.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CLC Bio company profile →
Synthesis Med Chem
HQ: United States
Website
- Description: Provider of small molecule drug discovery services, offering integrated drug discovery from hit identification to preclinical candidate nomination; medicinal and synthetic chemistry; custom synthesis; targeted protein degradation (PROTACs & molecular glues); antibody-drug conjugate development; and hit discovery supported by protein production and structural biology services from Viva Biotech.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Synthesis Med Chem company profile →
Synsight
HQ: France
Website
- Description: Provider of molecular modeling, bioinformatics, and structural biology services to accelerate research for pharmaceutical and cosmetic industries. Offerings include MT Bench microscopy-based screening of molecule effects on protein interactions, high-content phenotypic screening, AI/chemoinformatics for candidate design, a therapeutic portfolio focused on protein-RNA targets, and CRO support for protein design, diagnostic kits, and drug discovery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Synsight company profile →
Vividion Therapeutics
HQ: United States
Website
- Description: Provider of a proteome-wide chemoproteomic platform for drug and target discovery and small-molecule therapeutics in oncology and immunology, including programs for NRF2 inhibition in squamous lung, head, neck and esophageal cancers; NRF2 activation for inflammation-induced tissue injury; STAT3 targeting (incl. oral investigational VVD-130850 for advanced solid and hematologic tumors); and Werner helicase targeting for microsatellite instability cancers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vividion Therapeutics company profile →
RxData
HQ: United States
Website
- Description: Provider of a global market access data platform offering on-demand, automated pharmaceutical pricing and reimbursement insights. Solutions include comprehensive market access intelligence, exportable dashboards, real-time monitoring of 100+ sources, curated HTA/regulatory data, visible net price algorithms, and an internal data repository.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full RxData company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Benchling
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Benchling
2.2 - Growth funds investing in similar companies to Benchling
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Benchling
4.2 - Public trading comparable groups for Benchling
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →